MOAT-E (ARA) is a full-length MRP cMOAT subfamily transporter expressed inkidney and liver

Citation
Mg. Belinsky et Gd. Kruh, MOAT-E (ARA) is a full-length MRP cMOAT subfamily transporter expressed inkidney and liver, BR J CANC, 80(9), 1999, pp. 1342-1349
Citations number
45
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
BRITISH JOURNAL OF CANCER
ISSN journal
00070920 → ACNP
Volume
80
Issue
9
Year of publication
1999
Pages
1342 - 1349
Database
ISI
SICI code
0007-0920(199907)80:9<1342:M(IAFM>2.0.ZU;2-S
Abstract
Multidrug resistance-associated protein (MRP) and the canalicular multispec ific organic anion transporter (cMOAT) are organic anion pumps that have be en linked to cytotoxic drug resistance. We previously reported the isolatio n of three human MRP/cMOAT-related transporters, MOAT-B (MRP4), MOAT-C (MRP 5) and MOAT-D (MRP3). In the present study we describe the fourth MRP/cMOAT -related transporter. We analysed ARA, a human cDNA reported to encode a 45 3 residue MRP-related transporter and found that it represents a fused tran script composed of MRP sequences and partial sequences of a novel transport er. The complete coding sequence of this novel transporter, which we design ated MOAT-E, was isolated. MOAT-E encodes a 1503 residue transporter that i s most closely related to MRP (45%), MOAT-D (44%) and cMOAT (39%), both in terms of amino acid identity and sharing a common topology in which similar to 17 transmembrane spanning helices are distributed within three membrane spanning domains. RNA blot analysis indicated that MOAT-E expression is re stricted to kidney and liver. These observations suggest that MOAT-E may fu nction as an organic anion transporter involved in cellular detoxification and possibly in the hepatobiliary and renal excretion of xenobiotics and/or endogenous metabolites. Isolation of MOAT-E helps to define the MRP/cMOAT subfamily of transporters.